These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8887733)

  • 1. On the in-vivo modulation of neostriatal dopamine release by fluoxetine and 5-hydroxy-L-tryptophan in conscious rats.
    Li XM; Perry KW; Fuller RW
    J Pharm Pharmacol; 1996 Aug; 48(8):825-8. PubMed ID: 8887733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDMA induced dopamine release in vivo: role of endogenous serotonin.
    Koch S; Galloway MP
    J Neural Transm (Vienna); 1997; 104(2-3):135-46. PubMed ID: 9203077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study.
    Matsumoto M; Yoshioka M; Togashi H; Ikeda T; Saito H
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):621-9. PubMed ID: 8738295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.
    Li SX; Perry KW; Wong DT
    Neuropharmacology; 2002 Feb; 42(2):181-90. PubMed ID: 11804614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement in extracellular serotonin levels by 5-hydroxytryptophan loading after administration of WAY 100635 and fluoxetine.
    Dreshfield-Ahmad LJ; Thompson DC; Schaus JM; Wong DT
    Life Sci; 2000 Apr; 66(21):2035-41. PubMed ID: 10823343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
    Bymaster FP; Zhang W; Carter PA; Shaw J; Chernet E; Phebus L; Wong DT; Perry KW
    Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
    Gudelsky GA; Nash JF
    J Neurochem; 1996 Jan; 66(1):243-9. PubMed ID: 8522960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse.
    Knobelman DA; Hen R; Lucki I
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1083-91. PubMed ID: 11504805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats.
    Malone DT; Taylor DA
    Br J Pharmacol; 1999 Sep; 128(1):21-6. PubMed ID: 10498830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
    Li XM; Perry KW; Wong DT
    Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-L-tryptophan or fluoxetine.
    Sémont A; Fache M; Héry F; Faudon M; Youssouf F; Héry M
    J Neuroendocrinol; 2000 Aug; 12(8):736-44. PubMed ID: 10929085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex.
    Yoshino T; Nisijima K; Katoh S; Yui K; Nakamura M
    Neurochem Int; 2002 Apr; 40(4):355-60. PubMed ID: 11792466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus.
    Fuller RW; Perry KW; Hemrick-Luecke SK; Engleman E
    J Pharm Pharmacol; 1996 Jan; 48(1):68-70. PubMed ID: 8722499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats.
    Perry KW; Fuller RW
    J Neural Transm (Vienna); 1997; 104(8-9):953-66. PubMed ID: 9451727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus L-5-hydroxytryptophan.
    Perry KW; Fuller RW
    J Pharm Pharmacol; 1993 Aug; 45(8):759-61. PubMed ID: 7901377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine.
    Molina-Holgado E; Dewar KM; Descarries L; Reader TA
    J Pharmacol Exp Ther; 1994 Aug; 270(2):713-21. PubMed ID: 8071864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine.
    Shioda K; Nisijima K; Yoshino T; Kato S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):633-40. PubMed ID: 15276688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.